Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Conversion Therapy”

230 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 230 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07263360
What this trial is testing

Iparomlimab and Tuvonralimab Injection Combined With GemOX and Lenvatinib as Conversion Therapy for Initially Potentially Resectable Intrahepatic Cholangiocarcinoma and Gallbladder Cancer

Who this might be right for
BTC
Tianjin Medical University Cancer Institute and Hospital 29
Testing effectiveness (Phase 2)Looking for participantsNCT06405139
What this trial is testing

Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 36
Large-scale testing (Phase 3)Looking for participantsNCT06345339
What this trial is testing

Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Who this might be right for
Hypothyroidism
AbbVie 2,800
Testing effectiveness (Phase 2)UnknownNCT06153368
What this trial is testing

Cadonilimab Plus mFOLFIRINOX as Conversion Therapy in LAPC

Who this might be right for
Pancreatic Cancer
The First Affiliated Hospital with Nanjing Medical University 30
Not applicableStudy completedNCT02482974
What this trial is testing

Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients

Who this might be right for
Liver Transplant Recipients
Ege University 66
Testing effectiveness (Phase 2)Study completedNCT04694183
What this trial is testing

The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer

Who this might be right for
Stomach Neoplasms
Quan Wang 37
Testing effectiveness (Phase 2)Looking for participantsNCT03401294
What this trial is testing

Conversion From Unresectable To Resectable Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
University of Saskatchewan 32
Not applicableStudy completedNCT00439439
What this trial is testing

ACHAT-STUDY, Alternative Treatment of Chronic Globus Sensations

Who this might be right for
GlobusDeglutition Disorders
Technical University of Munich 40
Testing effectiveness (Phase 2)UnknownNCT06218004
What this trial is testing

Envafolimab Combined With Chemotherapy in Neoadjuvant and Conversion Therapy for Head and Neck Squamous Cell Carcinoma

Who this might be right for
Efficacy and Safety
Hairong Liu 40
Not applicableNot Yet RecruitingNCT07350447
What this trial is testing

Predictors of Laparoscopy Conversion in Adhesive Small Bowel Obstruction

Who this might be right for
Adhesive Small Bowel Obstruction
Almazov National Medical Research Centre 170
Not applicableStudy completedNCT01590992
What this trial is testing

Treatment of Globus Sensations With Psychotherapy

Who this might be right for
Somatoform DisordersGlobus Hystericus
University Hospital, Basel, Switzerland 175
Post-approval studies (Phase 4)Study completedNCT01140581
What this trial is testing

Optimal Timing of Dronedarone Initiation After Conversion in Patients With Persistent Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Sanofi 402
Not applicableUnknownNCT06194695
What this trial is testing

DEB-TACE, Lenvatinib and Anti-PD(L)1 Antibody as Conversion Therapy for Intrahepatic Cholangiocarcinoma

Who this might be right for
Cholangiocarcinoma Non-resectable
Ze-yang Ding, MD 100
Not applicableStudy completedNCT03871426
What this trial is testing

Manual Therapy Effects on Upper and Lower Esophageal Sphincter Pressures

Who this might be right for
Gastroesophageal Reflux DiseaseGlobus Pharyngeus
University Hospital, Motol 54
Not applicableNot Yet RecruitingNCT07208526
What this trial is testing

Trial of Surgical Decision-Making Guided by TDTP-RECIST

Who this might be right for
Intrahepatic Cholangiocarcinoma (Icc)Conversion TherapyTDTP-RECIST+1 more
Shanghai Zhongshan Hospital 270
Not applicableStudy completedNCT06022393
What this trial is testing

CBT Training for Cognitive Reappraisal as an Intervention for Patients With Functional Tremor - an EEG Study

Who this might be right for
Functional Movement Disorder
Medical University of Graz 20
Large-scale testing (Phase 3)WithdrawnNCT05082571
What this trial is testing

Study to Evaluate the Safety and Efficacy of Oral Vadadustat in Pediatric Participants With Anemia of Chronic Kidney Disease

Who this might be right for
Anemia of Chronic Kidney Disease
Akebia Therapeutics
Not applicableEnded earlyNCT03398512
What this trial is testing

HIPEC and Systemic Chemotherapy in Unresectable Peritoneal Metastases From Colorectal Cancer

Who this might be right for
Peritoneal Metastases From Colorectal Cancer
Wuhan University 15
Not applicableLooking for participantsNCT06405321
What this trial is testing

Conversion or Neoadjuvant Therapy in Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Guangxi Medical University 2,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07268794
What this trial is testing

CONVERT-HB1: Radical Prostatectomy After Systemic Therapy for High-volume Metastatic Hormone-sensitive Prostate Cancer

Who this might be right for
Metastatic Prostate CancerProstate Cancer (Adenocarcinoma)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Fudan University 112
Load More Results